M. Fonseca

Boosting half-life and effector functions of therapeutic antibodies by Fc-engineering: An interaction-function review.

Marcus Rafael Lobo Bezerra, C. F. C. Fernandes, G. Furtado, 2018, International journal of biological macromolecules.

Circumventing the side effects of L-asparaginase.

Raphael Trevizani, S. B. Morais, T. Souza, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Dynamics of antibody response to CoronaVac vaccine

M. Fonseca, Luiz Odorico Monteiro de Andrade, Tamiris de Fátima Goebel de Souza, 2022, Journal of medical virology.

Seroprevalence and factors associated with SARS-CoV-2 infection among education workers after the first wave: the first cross-sectional study in Brazil

M. Almeida, C. Alencar, Fernanda Montenegro de Carvalho Araújo, 2022, Revista da Sociedade Brasileira de Medicina Tropical.

Expression of a recombinant bacterial l-asparaginase in human cells

Raquel Caminha Dantas, G. Furtado, M. Fonseca, 2019, BMC Research Notes.

Antibody response 6 months after the booster dose of Pfizer in previous recipients of CoronaVac

M. Fonseca, Fernanda Montenegro de Carvalho Araújo, Ludmilla Freire Caetano, 2022, Journal of medical virology.

Persistently positive SARS‐CoV‐2‐specific IgM during 1‐year follow‐up

M. Fonseca, Luiz Odorico Monteiro de Andrade, Fernanda Montenegro de Carvalho Araújo, 2022, Journal of medical virology.

Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine

M. Fonseca, Fernanda Montenegro de Carvalho Araújo, L. O. M. de Andrade, 2022, Emerging infectious diseases.

Engineering of single-domain antibodies for next generation snakebite antivenoms.

A. Soares, J. Zuliani, S. S. Pereira, 2021, International journal of biological macromolecules.

Influence of age, gender, previous SARS-CoV-2 infection, and pre-existing diseases in antibody response after COVID-19 vaccination: A review

M. Fonseca, Fernanda Montenegro de Carvalho Araújo, T. C. Matsui, 2023, Molecular Immunology.